Triazole‐Derived Ruthenium(II) Complexes as Novel Candidates for Cancer Therapy
ChemPlusChem · 2025
DOI: 10.1002/cplu.202400775 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemPlusChem, 2025. Verfasst von Oscar A Lenis-Rojas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Tecnologia Química e Biológica António Xavier, ITQB NOVA, Av. da República, 2780-157, Oeiras, Portugal. Hauptthemen laut MEDLINE: Ruthenium, Antineoplastic Agents, Triazoles, Coordination Complexes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: FEDER funds, FCT - Fundação para a Ciência e a Tecnologia, Associate Laboratory for Green Chemistry - LAQV, FCT/MCTES.
Abstract (Originalsprache)
The first examples of Ru(II) η 6 ‐arene (benzene and p ‐cymene) complexes containing a bidentate triazolylidene‐triazolide ligand have been prepared and fully characterized. Their antiproliferative effect has been investigated against tumour cells A2780 (ovarian carcinoma), HCT116 (colorectal carcinoma), and HCT116dox (colorectal carcinoma resistant to doxorubicin), and in human dermal fibroblasts. The Ru complex bearing the p ‐cymene arene group exhibited a stronger antiproliferative effect across all tested cell lines, while the benzene‐containing complex displayed higher selectivity toward tumor cells. Both complexes induced apoptosis, likely through ROS production (in the benzene complex), and inhibited tumorigenic processes, including cell migration and angiogenesis. In zebrafish models, they showed strong selectivity for cancer cells with minimal toxicity to healthy cells, effectively reducing the proliferation of HCT116 colorectal cancer cells. This study provides the first in vivo evidence of the anticancer potential of Ru triazolylidenes in zebrafish models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Tecnologia Química e Biológica António Xavier, ITQB NOVA, Av. da República, 2780-157, Oeiras, Portugal.
- Associate Laboratory i4HB - Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, Campus de Caparica, 2829-516, Caparica, Portugal.
- Departamento de Zoología Genética y Antropología Física, Facultad de Veterinaria, Universidad de Santiago de Compostela, Campus de Lugo, 27002, Lugo, Spain.
- Laboratory of Zebrafish, Department of Medical Genetics and Genomic Medicine School of Medical Sciences, University of Campinas (UNICAMP), Sao Paulo, Brazil.
- LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, 2829-516, Caparica, Portugal.
ORCID-Profile: Beatriz Royo
Förderung
- FEDER funds
- FCT - Fundação para a Ciência e a Tecnologia
- Associate Laboratory for Green Chemistry - LAQV, FCT/MCTES
- Research Unit on Applied Molecular Biosciences - UCIBIO
- Associate Laboratory Institute for Health and Bioeconomy - i4HB
- NANOHEAT
- FCT
- POPH-Programa Operacional Potencial Humano
Zitieren
APA
Lenis-Rojas, O. A., Roma-Rodrigues, C., Carvalho, B., Andrade, V., Friães, S., Cabezas-Sainz, P., Araujo Fernández, J. A., Fernández Vila, S., Arana, Á. J., Sanchez, L., Baptista, P. V., Gomes, C. S. B., Fernandes, A. R., & Royo, B. (2025). Triazole‐Derived Ruthenium(II) Complexes as Novel Candidates for Cancer Therapy. ChemPlusChem. https://doi.org/10.1002/cplu.202400775
Vancouver
Lenis-Rojas OA, Roma-Rodrigues C, Carvalho B, Andrade V, Friães S, Cabezas-Sainz P, et al. Triazole‐Derived Ruthenium(II) Complexes as Novel Candidates for Cancer Therapy. ChemPlusChem. 2025. doi:10.1002/cplu.202400775
BibTeX
@article{LenisRojas2025,
author = {Lenis-Rojas, Oscar A and Roma-Rodrigues, Catarina and Carvalho, Beatriz and Andrade, Vasco and Friães, Sofia and Cabezas-Sainz, Pablo and Araujo Fernández, Jhonathan Angel and Fernández Vila, Sabela and Arana, Álvaro J and Sanchez, Laura and Baptista, Pedro V and Gomes, Clara S B and Fernandes, Alexandra R and Royo, Beatriz},
title = {Triazole‐Derived Ruthenium(II) Complexes as Novel Candidates for Cancer Therapy},
journal = {ChemPlusChem},
year = {2025},
doi = {10.1002/cplu.202400775}
}
EUVIMED